Display options
Share it on

Am J Dermatopathol. 2021 Dec 01;43(12):e230-e233. doi: 10.1097/DAD.0000000000001993.

Scurvy and Tinea Corporis Simulating Leukocytoclastic Vasculitis.

The American Journal of dermatopathology

Haley D Heibel, Sidra Ibad, Yusuf Chao, Komal K Patel, Jake Hutto, Lucas E Redd, Daniel R Nussenzveig, Kimberly H Laborde, Clay J Cockerell, Kyawt Shwin

Affiliations

  1. Cockerell Dermatopathology, Dallas, TX.
  2. Icahn School of Medicine at Mount Sinai, New York, NY.
  3. Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX.
  4. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.
  5. Department of Pathology, Veterans Affairs North Texas Health Care System, Dallas, TX.
  6. Department of Pathology, UT Southwestern Medical Center, Dallas, TX.
  7. Dermatology and Skin Surgery Clinic, Alexandria, LA.
  8. Department of Dermatology, UT Southwestern Medical Center, Dallas, TX; and.
  9. Rheumatology Section, Veterans Affairs North Texas Health Care System, Dallas, TX.

PMID: 34086641 DOI: 10.1097/DAD.0000000000001993

Abstract

ABSTRACT: Leukocytoclastic vasculitis (LCV) is a small vessel inflammatory condition considered to be caused by circulating immune complexes and often occurs after an acute infection or exposure to a new medication, although it may be associated with an underlying systemic disease or be idiopathic in nature. It is important to determine the etiology, identify the extent of the disease for early intervention and appropriate management, and treat and/or eliminate the underlying cause. Here, we report cases of scurvy and tinea corporis that presented with histopathologic features of LCV and had significant clinical improvement with treatment of the underlying etiologies. These cases emphasize that histopathologic features of early evolving LCV may be seen in other settings including scurvy and tinea corporis. Appropriate treatment of the underlying condition is important for optimized patient management.

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Conflict of interest statement

The authors declare no conflicts of interest.

References

  1. Koutkia P, Mylonakis E, Rounds S, et al. Leucocytoclastic vasculitis: an update for the clinician. Scand J Rheumatol. 2001;30:315–322. - PubMed
  2. Lotti T, Ghersetich I, Comacchi C, et al. Cutaneous small-vessel vasculitis. J Am Acad Dermatol. 1998;39:667–690. - PubMed
  3. James WD, Berger TG, Elston DM, et al. Andrews' Diseases of the Skin: Clinical Dermatology. 12th ed. Philadelphia, PA: Elsevier; 2016. - PubMed
  4. Bachmeyer C, Moguelet P, Marciano S, et al. Extensive purpuric lesions due to vitamin C deficiency and leucocytoclastic vasculitis as the initial sign of lung adenocarcinoma. Clin Exp Dermatol. 2019;44:e53–e54. - PubMed
  5. Francescone MA, Levitt J. Scurvy masquerading as leukocytoclastic vasculitis: a case report and review of the literature. Cutis. 2005;76:261–266. - PubMed
  6. Eidbo J, Sanchez RL, Tschen JA, et al. Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome. Am J Surg Pathol. 1993;17:110–116. - PubMed
  7. deShazo RD, Feldlaufer MF, Mihm MC, et al. Bullous reactions to bedbug bites reflect cutaneous vasculitis. Am J Med. 2012;125:688–694. - PubMed

Publication Types